Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-ß signaling

Bioscience Reports

Volumn 37, Issue 4, 2017, Pages

  Sun, Nianfeng ^a   Xue, Yu ^a   Dai, Ting ^a   Li, Xiding ^a   Zheng, Nanxiang ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CHOLECYSTOKININ OCTAPEPTIDE; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRIPARTITE MOTIF CONTAINING 25; TRIPARTITE MOTIF PROTEIN; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR; TRIM25 PROTEIN, HUMAN; TUMOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL LINE; CANCER TISSUE; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; HCT 116 CELL LINE; HT-29 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRIPARTITE MOTIF PROTEINS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 85025831507     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20170805     Document Type: Article

References (27)

1. Siegel, R., Desantis, C. and Jemal, A. (2014) Colorectal cancer statistics, 2014. CA Cancer J. Clin. 64, 104–117
2. Miller, K.D., Siegel, R.L., Lin, C.C., Mariotto, A.B., Kramer, J.L., Rowland, J.H. et al. (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J. Clin. 66, 271–289
3. Meyerhardt, J.A. and Mayer, R.J. (2005) Systemic therapy for colorectal cancer. N. Engl. J. Med. 352, 476–487
4. Hayashi, M., Inoue, Y., Komeda, K., Shimizu, T., Asakuma, M., Hirokawa, F. et al. (2010) Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg. 10, 10–27
5. Fong, Y., Fortner, J., Sun, R.L., Brennan, M.F. and Blumgart, L.H. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230, 309–318
6. Bernassola, F., Karin, M., Ciechanover, A. and Melino, G. (2008) The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14, 10–21
7. Glickman, M.H. and Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373–428
8. Mukhopadhyay, D. and Riezman, H. (2007) Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315, 201–205
9. Schnell, J.D. and Hicke, L. (2003) Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 278, 35857–35860
10. Hatakeyama, S. (2011) TRIM proteins and cancer. Nat. Rev. Cancer 11, 792–804
11. Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L. et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916–920
12. Gack, M.U., Albrecht, R.A., Urano, T., Inn, K.S., Huang, I.C., Carnero, E. et al. (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439–449
13. Inn, K.S., Lee, S.H., Rathbun, J.Y., Wong, L.Y., Toth, Z., Machida, K. et al. (2011) Inhibition of RIG-I-mediated signaling by Kaposi’s sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85, 10899–10904
14. Lee, N.R., Kim, H.I., Choi, M.S., Yi, C.M. and Inn, K.S. (2015) Regulation of MDA5-MAVS antiviral signaling axis by TRIM25 through TRAF6-mediated NF-kappaB activation. Mol. Cells 38, 759–764
15. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M. et al. (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417, 871–875
16. Simooka, H., Oyama, T., Sano, T., Horiguchi, J. and Nakajima, T. (2004) Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol. Int. 54, 595–602
17. Sakuma, M., Akahira, J., Suzuki, T., Inoue, S., Ito, K., Moriya, T. et al. (2005) Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer. Gynecol. Oncol. 99, 664–670
18. Nakayama, H., Sano, T., Motegi, A., Oyama, T. and Nakajima, T. (2005) Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol. Int. 55, 707–715
19. Qin, Y., Cui, H. and Zhang, H. (2016) Overexpression of TRIM25 in lung cancer regulates tumor cell progression. Technol. Cancer Res. Treat. 15, 707–715
20. Zhu, Z., Wang, Y., Zhang, C., Yu, S., Zhu, Q., Hou, K. et al. (2016) TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-beta signaling. Sci. Rep. 6, 19070
21. Yang, H., Lu, X., Liu, Z., Chen, L., Xu, Y., Wang, Y. et al. (2015) FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. Oncotarget 6, 6310–6325
22. Song, L., Xie, X., Yu, S., Peng, F. and Peng, L. (2016) MicroRNA-126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer. Mol. Med. Rep. 13, 1204–1210
23. Horie, K., Urano, T., Ikeda, K. and Inoue, S. (2003) Estrogen-responsive RING finger protein controls breast cancer growth. J. Steroid Biochem. Mol. Biol. 85, 101–104
24. Markowitz, S.D. and Bertagnolli, M.M. (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460
25. Friedl, P. and Wolf, K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362–374
26. Huber, M.A., Kraut, N. and Beug, H. (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548–558
27. Yang, J. and Weinberg, R.A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818–829